P00782 (SUBT_BACAM) Bacillus amyloliquefaciens (Bacillus velezensis)

Subtilisin BPN' UniProtKBInterProSTRINGInteractive Modelling

382 aa; Sequence (Fasta) ; 3 identical sequences: Bacillus amyloliquefaciens: A0A9P1JG13; Bacillus subtilis: A0A7U5AV24; Bacillus amyloliquefaciens: D4PBI3

Available Structures

65 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Prosubtilisin Substrate Complex of Subtilisin SUBT_BACAM
3cnq
 Heteromer
37-382
5×ZN;
Assess
Azide complex of Engineered Subtilisin SUBT_BACAM
3bgo
 Heteromer
37-382
1×AZI; 4×ZN;
Assess
Substrate Complex of Fluoride-sensitive Engineered Subtilisin SUBT_BACAM
3co0
 Heteromer
37-382
4×ZN;
Assess
SUBTILISIN BPN' PROSEGMENT (77 RESIDUES) COMPLEXED WITH A MUTANT SUBTILISIN BPN' (266 RESIDUES). CR…
1spb
 Heteromer
37-382
1×NA;
Assess
Crystal structure of thymoligase, a substrate-tailored peptiligase variant
5ox2
 Heteromer
98-382
4×SO4;
Assess
crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59K, in pH 9 cry…
1to2
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 2×CIT; 3×15P;
Assess
crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59A mutant
1tm5
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 3×CIT; 3×1PE;
Assess
Crystal Structure of the Complex of Subtilisin BPN' with Chymotrypsin Inhibitor 2 at 1.5 Angstrom R…
1lw6
 Heteromer
P01053; 		108-382
1×CA; 4×SO4;
Assess
Crystal structure of serine protease inhibitor POIA1 in complex with subtilisin BPN
1v5i
 Heteromer
Q7M4T6; 		108-382
2×SO4; 1×CA; 16×GOL;
Assess
Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 E60A mutant
1y34
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 3×CIT; 4×15P;
Assess
Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 T58A mutant
1y1k
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 3×CIT; 3×15P;
Assess
crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59k mutant
1tm3
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 2×CIT; 3×1PE;
Assess
crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59Y mutant
1tm7
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 3×CIT; 4×1PE;
Assess
Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59R/E60S mutant
1y4a
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 1×CIT; 2×15P;
Assess
crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59F mutant
1tmg
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 3×CIT; 4×1PE; 1×15P;
Assess
crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 Y61A mutant
1to1
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 2×CIT; 4×1PE;
Assess
Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 R62A mutant
1y3c
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 3×CIT; 4×15P;
Assess
crystal structure of the complex of subtilsin BPN'with chymotrypsin inhibitor 2 M59G mutant
1tm4
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 2×CIT; 3×1PE;
Assess
CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2
1tm1
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 3×CIT; 4×1PE;
Assess
Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 F69A mutant
1y3f
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 3×CIT; 3×15P;
Assess
Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 T58P mutant
1y33
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 3×CIT; 3×15P;
Assess
Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 E60S mutant
1y3b
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 3×CIT; 3×15P;
Assess
Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 R67A mutant
1y3d
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 3×CIT; 4×15P;
Assess
MOLECULAR RECOGNITION AT THE ACTIVE SITE OF SUBTILISIN BPN': CRYSTALLOGRAPHIC STUDIES USING GENETIC…
3sic
 Heteromer
P01006; 		108-382
4×CA;
Assess
REFINED CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' AND STREPTOMYCES SUBTILISIN INHIBITOR A…
2sic
 Heteromer
P01006; 		108-382
4×CA;
Assess
Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 R65A mutant
1y48
 Heteromer
Q40059; 		108-382
1×CA; 1×NA; 3×CIT; 3×15P;
Assess
Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59R/E60S mutant
1y4d
 Heteromer
Q40059; 		108-382
1×CA; 1×NA;
Assess
STRUCTURAL COMPARISON OF TWO SERINE PROTEINASE-PROTEIN INHIBITOR COMPLEXES. EGLIN-C-SUBTILISIN CARL…
2sni
 Heteromer
P01053; 		108-382
2×CA;
Assess
REFINED CRYSTAL STRUCTURES OF SUBTILISIN NOVO IN COMPLEX WITH WILD-TYPE AND TWO MUTANT EGLINS. COMP…
1sbn
 Heteromer
P01051; 		108-382
2×CA;
Assess
MOLECULAR RECOGNITION AT THE ACTIVE SITE OF SUBTILISIN BPN': CRYSTALLOGRAPHIC STUDIES USING GENETIC…
5sic
 Heteromer
P01006; 		108-382
4×CA;
Assess
REFINED CRYSTAL STRUCTURES OF SUBTILISIN NOVO IN COMPLEX WITH WILD-TYPE AND TWO MUTANT EGLINS. COMP…
1sib
 Heteromer
P01051; 		108-382
2×CA;
Assess
Crystal structure of Peptiligase mutant - M222P/L217H/A225N/F189W/N218D
7am7
 Heteromer
P01051; 		108-382
9×GOL; 5×SO4; 1×PGE;
Assess
Crystal structure of Peptiligase mutant - L217H/M222P/A225N/F189W
7am6
 Heteromer
P01051; 		108-382
8×GOL; 2×TAR;
Assess
Crystal structure of aqualigase
8h7o
monomer108-382
1×CA; 2×IPA;
Assess
SUBTILISIN BPN' AT 1.6 ANGSTROMS RESOLUTION: ANALYSIS OF DISCRETE DISORDER AND COMPARISON OF CRYSTA…
1sup
monomer108-382
1×CA; 1×NA; 1×PMS;
Assess
Crystal structure of Peptiligase mutant - M222P
7am3
monomer108-382
4×GOL; 2×SO4;
Assess
Anion-triggered Engineered Subtilisin SUBT_BACAM
3f49
monomer108-382
1×NA;
Assess
LARGE INCREASES IN GENERAL STABILITY FOR SUBTILISIN BPN(PRIME) THROUGH INCREMENTAL CHANGES IN THE F…
1s01
monomer108-382
1×CA; 2×IPA;
Assess
CALCIUM-INDEPENDENT SUBTILISIN BY DESIGN
1sub
monomer108-382
1×CA; 1×K; 1×ACN;
Assess
SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) MUTANT (M50F, N76D, G169A, Q206C, N218S, K256Y)
1sbh
monomer108-382
2×CA;
Assess
SUBTILISIN MUTANT 8321
1ak9
monomer108-382
2×CA; 1×NA; 2×IPA;
Assess
SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP…
1yja
monomer108-382
2×CA;
Assess
SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP…
1yjb
monomer108-382
2×CA;
Assess
SUBTILISIN MUTANT 8324
1aqn
monomer108-382
2×CA; 2×UNX; 2×IPA;
Assess
SUBTILISIN BPN' MUTANT 8324 IN CITRATE
1au9
monomer108-382
2×CA; 2×UNX; 2×IPA;
Assess
SUBTILISIN BPN' FROM BACILLUS AMYLOLIQUEFACIENS, MUTANT
1sue
monomer108-382
1×NA; 1×DFP;
Assess
SUBTILISIN BPN' MUTANT 7186
1a2q
monomer108-382
2×CA; 2×ACN;
Assess
SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP…
1yjc
monomer108-382
2×CA;
Assess
THE THREE-DIMENSIONAL STRUCTURE OF BACILLUS AMYLOLIQUEFACIENS SUBTILISIN AT 1.8 ANGSTROMS AND AN AN…
2st1
monomer108-382
2×CA; 1×SO4;
Assess
Crystal structure of Peptiligase mutant - L217H/M222P
7am4
monomer108-382
3×GOL; 4×SO4;
Assess
Crystal structure of aqualigase bound with Suc-AAPF
8h7p
monomer108-382
1×CA; 1×PGE;
Assess
CALCIUM INDEPENDENT SUBTILISIN BPN' MUTANT
1gnv
monomer108-382
Assess
CALCIUM-INDEPENDENT SUBTILISIN BY DESIGN
1sud
monomer108-382
2×CA; 1×K; 1×ACN;
Assess
EFFECTS OF ENGINEERED SALT BRIDGES ON THE STABILITY OF SUBTILISIN BPN
1s02
monomer108-382
2×CA; 1×SO4;
Assess
THE THREE-DIMENSIONAL STRUCTURE OF BACILLUS AMYLOLIQUEFACIENS SUBTILISIN AT 1.8 ANGSTROMS AND AN AN…
1st2
monomer108-382
2×CA; 1×SO4;
Assess
Subtilisin BPN' from Bacillus amyloliquefaciens, crystal growth mutant
1dui
monomer108-382
1×NA; 1×DFP;
Assess
SUBTILISIN BPN' 8397 (E.C. 3.4.21.14) MUTANT (M50F, N76D, G169A, Q206C, N218S)
1sbi
monomer108-382
1×CA;
Assess
SELENOSUBTILISIN BPN
1ubn
monomer108-382
2×CA;
Assess
ATOMIC COORDINATES FOR SUBTILISIN BPN (OR NOVO)
1sbt
monomer108-382
Assess
A COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF SUBTILISIN BPN AND SUBTILISIN NOVO
2sbt
monomer108-382
1×ACN;
Assess
Crystal structure of Omniligase mutant W189F
7am8
monomer109-382
1×HIS; 1×AKR; 2×NA; 1×CL;
Assess
Crystal structure of Peptiligase mutant - L217H/M222P/A225N
7am5
monomer109-382
2×NA;
Assess
CALCIUM-INDEPENDENT SUBTILISIN BY DESIGN
1suc
monomer111-382
1×K; 1×ACN;
Assess
SUBTILISIN BPN
1gns
monomer111-382
1×ACN;
Assess
SUBTILISIN BPN
1sua
monomer111-382
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3whi.1.Amonomer0.8736-382
1×CA;86.36
Assess